MELLETT PAUL J has filed 7 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 7500 shares of ENANTA PHARMACEUTICALS INC ($ENTA) on February 12, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | A | Common Stock | 7500 | $0.00 | 99,210.0000 | 0 | 8.18% | 0.00% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | F | Common Stock | 3326 | $5.59 | 95,884.0000 | 0 | 3.35% | 0.00% |
| Dec. 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | S | Common Stock | 2591 | $8.06 | 91,710.0000 | 0 | 2.75% | 0.00% |
| Dec. 1, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | F | Common Stock | 1595 | $8.60 | 94,301.0000 | 0 | 1.66% | 0.00% |
| Nov. 27, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | A | Stock Option (right to buy) | 81000 | $0.00 | 81,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | A | Common Stock | 3320 | $0.00 | 96,869.0000 | 0 | 3.55% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | MELLETT PAUL J | Chief Fin. & Admin Officer | F | Common Stock | 973 | $12.41 | 95,896.0000 | 0 | 1.00% | 0.00% |